1 of 100
NEXT
1. SXC Health Solutions
3-year average
Revenue Growth: 151%
Profit Growth: 65%
Total Return: 105%
SXC is both a pharmacy benefits manager (PBM) and a service provider to PBMs. With some $72 billion in branded drugs losing patent protection in the next five years, sales of generic alternatives are likely to rise. SXC's PBM unit, which acts as middleman between the insurance company and the pharmacy, could be the beneficiary: It makes more money each time a person uses a generic drug rather than a branded drug. Health care reform also means more people will be covered by Medicaid, which could benefit both of SXC's business lines.

SXC also stands to gain from growth in the use of specialty drugs like those for rheumatoid arthritis. SXC expanded its contract with one of its clients, HealthSpring, which focuses on specialty drugs, and acquired MedFusionRx, a specialty pharmacy provider, in December.
Get stock quote: SXCI
Revenue ($ millions): $2593.9
Net Income ($ millions): $68.2
Industry: Health Care
Network with SXC Health Solutions
From the September 26, 2011 issue.
Revenue and profit figures reflect the four quarters ended on or before April 30,2011.
Total return is through June 30, 2011.
SXC Health Solutions incorporated in Canada.

Green Plains Renewable Energy 299%
SXC Health Solutions 151%
Discovery Communications 105%
Sturm Ruger & Co 848%
Cirrus Logic 340%
Hi-Tech Pharmacal 234%
Green Mountain Coffee Roasters 120%
Netflix 116%
Acme Packet 108%
To qualify, a company -- domestic or foreign -- must be trading on a major U.S. stock exchange; file quarterly reports to the SEC; have a minimum market... More